Overcoming Challenges in a Multicenter Oncology Clinical Tri...
12 Aug 2023
The study aimed to characterize the pharmacokinetic profile and to assess the bioequivalence of Liposomal doxorubicin (TEST) in comparison to RLD (Cae...
Accelerating Patient Recruitment: Topical Tacrolimus for Ato...
07 Jul 2023
Successful Enrolment of 783 Patients across India, in Two Phase III Studies on Topical Tacrolimus for Atopic Dermatitis in Just 5 Months......
Address the Unmet Needs in Paediatric Drug Development with ...
06 Apr 2023
Address the Unmet Needs in Paediatric Drug Development with Lambda. Partner with Lambda for customized solutions at a project, program and com...
Critical Challenges to the Management of Imaging in Clinical...
06 Apr 2023
Clinical trials enable the development and access of new drugs to patients. Imaging is considered a valuable tool which forms the basis of robust res...
Breakthrough Therapy Designation from U.S. Food and Drug Adm...
31 Aug 2018
Major depressive disorder (MDD) affects approximately 16 million people in the U.S. and 121 million people worldwide. As per the report on global burd...
BRCA1 Gene Mutation: Women at Increased Risk of Aggressive U...
07 Aug 2018
BRCA1 and BRCA2 genes regulate the prosecution of tumor suppressor proteins in humans to repair damaged DNA. When one of these genes gets mutated, cel...
HER2 Positive Breast Cancer: New Treatment Horizon
05 May 2018
Introduction Breast cancer (BC) is one of the major cancers, second most common, in females worldwide. 1.7 billion Breast cancer Cases were reported i...
